Zachary Roberts - EVP of R&D at Allogene Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP of R&D
Issuer Symbol
ALLO on Nasdaq
All Insider Reports
All Insider Reports

Zachary Roberts - trading volume in the past year for Allogene Therapeutics, Inc.

Holdings reported by Zachary Roberts for Allogene Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 581,166 $1,028,663 $1.77 02 Feb 2026 Direct
Stock Option (Right to buy) 718,763 02 Feb 2026 Direct Common Stock
Restricted Stock Unit 203,307 02 Feb 2026 Direct Common Stock

Transactions reported by Zachary Roberts for Allogene Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.